Wayne Markowitz - 08 Dec 2025 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: CVP, JAPAC
Issuer ticker: EW
Reported as of: 08 Dec 2025
Net transaction value: -$50,144
SEC form: 4
Accepted by SEC: 08 Dec 2025, 17:50:03 UTC
Prior SEC filing: 15 Sep 2025
Next SEC filing: 11 May 2026
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Wayne Markowitz filed Form 4 for Edwards Lifesciences Corp (EW) on 08 Dec 2025.

Key facts

This page summarizes Wayne Markowitz's Form 4 filing for Edwards Lifesciences Corp (EW).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Dec 2025, 17:50.

Change

Previous filing in this sequence was filed on 15 Sep 2025.
Current net transaction value: -$50,144.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001991414 Primary reporting owner

Markowitz Wayne

Relationship: CVP, JAPAC
Address: ONE EDWARDS WAY, IRVINE
Signature: Linda J. Park, Attorney-in-Fact
Signature date: 08 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Sale

Transaction value: $50,144
Shares: -583
Change %: -3.2%
Price: $86.01
Shares after: 17,563
Date: 08 Dec 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.